Clinical Trial Update: A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 multicenter trial assessing safety, tolerability, and clinical activity of ALX-0171 in otherwise healthy infants and toddlers hospitalized with RSV lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ALX-0171

Snippet

Sponsor: Ablynx, a Sanofi company | Conditions: Respiratory Syncytial Virus Infection | Phase 1, Phase 2 | Status: COMPLETED